← Eichor
Study identifier: NCT05813236 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery

Condition: Gingivitis · Gingival Diseases · Periodontal Diseases  ·  Sponsor: Aesculap AG

PhaseNA
Planned participants84
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to prove that Novosyn Quick and Monosyn Quick are equivalent in early wound healing in adult patients undergoing resective periodontal surgery. In order to show equivalence between Novosyn Quick and Monosyn Quick EHS, which is composed of 3 parameters: clinical signs of reepithelization, clinical signs of haemostasis and clinical signs of inflammation, will be calculated for each suture 10 ± 5 days postoperatively and cannot differ more than 2 points. Furthermore, complications, the handling of the suture material, pain, satisfaction of the patient and bacterial contamination of the thread (optional) will also be assessed as secondary objectives.

This description comes directly from the study's public registry record.

Talk to the study team

Jaume García López, Dr.  ·  +3493586620  ·  info@bbraun.com

Jose Manuel Molina, Dr.  ·  info@bbraun.com

Always discuss trial participation with your own doctor first.

Locations (1)

Facultat d'Odontologia. Universitat Internacional de CatalunyaSant Cugat del Vallès, Catalonia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05813236